Pilot of IMPACT Intervention at the University of New Mexico

Sponsor
University of New Mexico (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04166994
Collaborator
(none)
20
1
2
27
0.7

Study Details

Study Description

Brief Summary

Kidney transplant recipients (KTR) are at greater risk of weight gain, diabetes and cardiovascular events post-transplant; but medications are limited in their effectiveness, and patients may face contraindications and unwanted side effects, given their complex post-transplant immunosuppression regimen. The investigators will pilot a randomized-controlled trial to test the feasibility and acceptability of a culturally-appropriate, multi-behavior (diet and exercise) lifestyle intervention for 20 American Indian, Hispanic/Latino(a), and White KTRs. Critical components of the pilot trial include: (a) an individually tailored exercise and diet plan with a physical therapist/exercise physiologist and a registered dietitian nutritionist, who will work closely with the post-transplant team to carefully monitor patient stability; and, (b) the use of the Twistle Patient Engagement Platform to follow-up with participants between their scheduled appointments and to collect all questionnaire data.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise and diet
  • Other: No Intervention: Usual Care
N/A

Detailed Description

In Improving Healthcare Outcomes in American Indian and Hispanic Transplant Recipients Using Culturally-Tailored Novel Technology (IMPACT), the investigators will pilot the feasibility and acceptability of a culturally-tailored, multi-behavior lifestyle intervention using a novel technology for 14-20 AI, HL, and White KT recipients. Because of KT recipients' varied stability immediately post-transplant, and the need to individually monitor their post-transplant immunosuppression regimen, a critical component of IMPACT will be an individually-tailored exercise and diet plan with a physical therapist/exercise physiologist and a registered dietitian nutritionist, who will work closely with the post-transplant team to carefully monitor patient stability. IMPACT will combine a personalized assessment of the patient's food preferences and access to exercise resources within their environment (based on a standard list of factors developed by the nutrition and rehabilitation experts) along with clinical specifications from the transplant team. The study is innovative because it addresses previous limitations, while adapting the intervention to meet the needs of the culturally-diverse ESKD population. The final innovation of the IMPACT Pilot is the use of the Twistle Patient Engagement Platform to follow-up with participants between their scheduled appointments, ensure adherence to the intervention, collect all questionnaire data, and enhance participant retention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized Control TrialRandomized Control Trial
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Improving Healthcare Outcomes in American Indian and Hispanic Transplant Recipients Using Culturally-Tailored Novel Technology (IMPACT)
Actual Study Start Date :
Nov 1, 2020
Anticipated Primary Completion Date :
Dec 21, 2022
Anticipated Study Completion Date :
Jan 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: IMPACT Intervention

Incorporate a rehabilitation approach to slowly increasing KT recipients' physical activity in addition to individualized dietary intervention at every post-transplant appointment through six months post-transplant, with follow-up at 12 months post-transplant.

Behavioral: Exercise and diet
IMPACT Intervention

Other: Usual Care

No exercise or diet specialization.

Other: No Intervention: Usual Care
No exercise or diet specialization.

Outcome Measures

Primary Outcome Measures

  1. Intervention Acceptability: Satisfaction [12 months]

    Client Satisfaction Questionnaire, rated 1-4, where higher satisfaction will indicate greater intervention acceptability

  2. Intervention Acceptability: Usability [12 months]

    System Usability Scale, rated 1-5, where higher scores indicate ease of usability

  3. Intervention feasibility: Retention [Through study completion, an average of 1 year]

    Retention rates

  4. Intervention feasibility: Missing data [Through study completion, an average of 1 year]

    Estimates of the expected rates of missing data

  5. Intervention feasibility: Attrition [Through study completion, an average of 1 year]

    Participant attrition will be measured by counting participants who do not continue with the study

  6. Intervention feasibility: Participation [Through study completion, an average of 1 year]

    Time required for study participation during every intervention session

Secondary Outcome Measures

  1. Medical records outcomes: Weight [Through study completion, an average of 1 year]

    Percent weight change

  2. Medical records outcomes: Lipids [Through study completion, an average of 1 year]

    Total cholesterol: Less than 200 mg/dL, LDL: Less than 100 mg/dL, HDL: 60 mg/dL or higher, Triglycerides: less than 150 mg/dL

  3. Medical records outcomes: HbA1c [Through study completion, an average of 1 year]

    HbA1c

  4. Patient reported outcomes: Sleep [Baseline, 1 year]

    Pittsburgh Sleep Quality Index will measure different aspects of sleep and becomes one composite score, where lower scores denote a healthier sleep quality

  5. Patient reported outcomes: QOL [Baseline, 1 year]

    We will use the PROMIS Scale v1.2 Global Health measure to assess quality of life (QOL), which includes items relevant to patients with kidney disease, including overall health, physical limitations, work, pain, energy, and emotional problems.

  6. Patient reported outcomes: Occupational [Baseline, 1 year]

    Occupational Functioning Subscale: CHART-SF rated 0-100, where higher scores indicate greater levels of participation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Received kidney transplant at UNMH

  2. Greater than 18 years of age

  3. Mentally competent

Exclusion Criteria:
  1. Children under the age of 18

  2. Incarcerated patients

  3. Pregnant women

  4. Active systemic infection

  5. Non-skin malignancy or melanoma in the past 2 years

  6. Known cognitive impairment

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of New Mexico Albuquerque New Mexico United States 87131

Sponsors and Collaborators

  • University of New Mexico

Investigators

  • Principal Investigator: Larissa Myaskovsky, PhD, University of New Mexico

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Larissa Myaskovsky, PhD, Associate Professor, Director: CHEK-D, University of New Mexico
ClinicalTrials.gov Identifier:
NCT04166994
Other Study ID Numbers:
  • 19-413 IMPACT
First Posted:
Nov 18, 2019
Last Update Posted:
Feb 2, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Larissa Myaskovsky, PhD, Associate Professor, Director: CHEK-D, University of New Mexico

Study Results

No Results Posted as of Feb 2, 2022